In addition, we observed statistically concurrent argumentation of TIPRL, LC3 and CD133 according to the progression of liver cancers, together indicating the complex interrelationships between levels of the biomarker candidates, TIPRL, LC3 and CD133 in liver cancer aggressiveness. Here, TIPRL is linked to liver cancer.